The invitation-based Genetic Health Information Network Summit convenes leaders from across healthcare, genomics, and technology in Nashville to discuss the digital infrastructure that personalized medicine needs to thrive.

The Think Tank on Advancing Precision Medicine in Rare Cancers is designed to be a one-day meeting uniting clinicians, researchers, industry, patient advocates, and patients in a unique format to promote collaboration, information sharing, and idea generation.

The Business of Biotech Conference convenes an audience of more than 400 biotechnology executives, entrepreneurs, venture capitalists, angel investors, and researchers from across the U.S. Learn more at https://www.moffitt.org/research-science/academic-and-industry-partnerships/office-of-innovation/business-of-biotech/.

GO2 for Lung Cancer’s Voices Summit will bring together people with lung cancer, caregivers, medical professionals, and supporters for education, training, connection, and direct advocacy with the federal government, the largest funder of cancer research. Learn more at https://na.eventscloud.com/ereg/index.php?eventid=769567&.

The 2024 Precision Medicine Tri-Conference will explore the latest research and technologies in precision medicine and precision health. Planned educational sessions include a keynote address and panel discussion on the state of innovation in diagnostic testing that will be chaired and moderated by PMC President Edward Abrahams as well as a presentation and panel discussion on implementing precision oncology that will be chaired and moderated by PMC Senior Vice President for Science Policy Daryl Pritchard. Learn more at www.triconference.com.

Participants in the Sepsis Alliance AMR Conference will explore innovative ideas, gain inspiration, and learn about practical technologies to manage sepsis and counteract the expanding challenge of antimicrobial resistance. Learn more at https://learn.sepsis.org/sepsis-alliance-amr-conference-2024?utm_source=Stakeholders&utm_medium=Stakeholders&utm_campaign=Stakeholders.

Dr. Marks will discuss the work of this important FDA center, which is responsible for assuring the safety and effectiveness of biological products, including vaccines, allergenic products, blood and blood products, and cellular, tissue, and gene therapies.